Internal Server Error

Reperio - About the company

Reperio is a series C company based in Portland (United States), founded in 2020 by Travis Rush and Matt Wallington. It operates as a Limited information available. Reperio has raised $52.7M in funding from Caduceus Capital Partners and Rogue Venture Partners. The company has 232 active competitors, including 55 funded and 13 that have exited. Its top competitors include companies like Function Health, Viome and 23andMe.

Company Details

Email ID
*****@reperiohealth.com, *****@reperiohealth.com, *****@reperiohealth.com, *****@reperiohealth.com, *****@reperiohealth.com
Registered Address
4784 SE 17TH AVE STE 120, PORTLAND, OR 97202
Key Metrics
Founded Year
2020
Location
Portland, United States
Stage
Series C
Total Funding
$52.7M in 8 rounds
Latest Funding Round
Ranked
Employee Count
27 as on Sep 30, 2026
Similar Companies
Sign up to download Reperio's company profile

Reperio's funding and investors

Reperio has raised a total funding of $52.7M over 8 rounds. Its first funding round was on Oct 15, 2020. Its latest funding round was a Series C round on May 21, 2025 for $*****. 1 investor participated in its latest round. Reperio has 5 institutional investors.

Here is the list of recent funding rounds of Reperio:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
May 21, 2025
2768535
Series C
7607267
2901626
6015304
3942100
May 23, 2024
1575124
Series B
1659318
8467171
2588474
6850915
Feb 09, 2024
1888918
Series B
2368434
1706541
1614196
lockAccess funding benchmarks and valuations. Sign up today!

Reperio's founders and board of directors

Founder? Claim Profile
The founders of Reperio are Travis Rush and Matt Wallington.
Here are the details of Reperio's key team members:

Reperio's Board of Directors

Reperio's board has 8 active members. Travis Rush, Matthew Wallington, TORY ADAMS, JUSTIN AUTREY, ELIZABETH CURTIS, Philip Hertik, ILDIKO CRIST and CHARLES JEWELL are independent board members.
Here is the list of Reperio's board of directors:
Name
Type
Representing
Status
Duration
Independent board member
-
Current
6y 0m
dnfqtfi
Independent board member
-
Current
5y 4m
lzwhsfi
Independent board member
-
Current
4y 2m
rmmkvkh
Independent board member
-
Current
7y 8m
lks{bwq
Independent board member
-
Current
9y 2m
qbrrrkz
Independent board member
-
Current
3y 1m
cgfyemu
Independent board member
-
Current
9y 3m
j{y{cdi
Independent board member
-
Current
7y 3m

Reperio's employee count trend

Reperio has 27 employees as of Sep 26. Here is Reperio's employee count trend over the years:
Employee count trend for Reperio
lockUncover Reperio's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Reperio's Competitors and alternates

Top competitors of Reperio include Function Health, Viome and 23andMe. Here is the list of Top 10 competitors of Reperio, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Function Health
Function Health
2022, Austin (United States), Series B
Provider of comprehensive lab testing and health monitoring membership services
$351M
75/100
2nd
Logo for Viome
Viome
2016, Bellevue (United States), Series D
Provider of a machine learning based bioinformatics solutions
$292M
74/100
3rd
Logo for 23andMe
23andMe
2006, Sunnyvale (United States), Acquired
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
$944M
73/100
4th
Logo for Helix
Helix
2015, San Francisco (United States), Series E
Provider of a genomic database for clinical research
$435M
73/100
5th
Logo for Color
Color
2013, Burlingame (United States), Series E
Provider of end-to-end Virtual clinic offering cancer-based solutions
$491M
66/100
6th
Logo for Ash
Ash
2019, New York City (United States), Series A
Provider of at-home diagnostics.
$47.5M
63/100
7th
Logo for Visby Medical
Visby Medical
2010, San Jose (United States), Series F
Provider of at-home tests for sexually transmitted infections with telehealth
$386M
60/100
8th
Logo for Sequential Bio
Sequential Bio
2019, New York City (United States), Series A
Provider of in-vivio microbiome testing platform for skin care
$7.5M
63/100
9th
Logo for Legacy
Legacy
2014, Cambridge (United States), Series B
Provider of at-home sperm testing and storage services
$47.7M
63/100
10th
Logo for LetsGetChecked
LetsGetChecked
2013, Dublin (Ireland), Series D
Online platform to order at home diagnostic tests for all health conditions
$285M
62/100
15th
Logo for Reperio
Reperio
2020, Portland (United States), Series C
Limited information available
$52.7M
60/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Reperio's competitors? Click here to see the top ones

Reperio's Investments and acquisitions

Reperio has made no investments or acquisitions yet.

Reports related to Reperio

Here is the latest report on Reperio's sector:

News related to Reperio

lockFilter this list
Media has covered Reperio for a total of 2 events in the last 1 year, 1 of them has been about partnerships and 1 about people movement.
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Reperio

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford